American National Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$124K Sell
1,438
-89
-6% -$7.91K 0.01% 280
2026
Q2
$138K Hold
1,527
– – 0.01% 283
2026
Q1
$122K Hold
1,527
– – 0.01% 278
2025
Q4
$130K Hold
1,527
– – 0.01% 281
2025
Q3
$119K Sell
1,527
-251
-14% -$19.6K 0.01% 275
2025
Q2
$139K Buy
1,778
+82
+5% +$6.12K 0.01% 284
2025
Q1
$123K Buy
1,696
+7
+0.4% +$501 0.01% 254
2024
Q4
$125K Hold
1,689
– – 0.01% 242
2024
Q3
$111K Hold
1,689
– – 0.01% 248
2024
Q2
$156K Hold
1,689
– – 0.02% 228
2024
Q1
$161K Hold
1,689
– – 0.02% 213
2023
Q4
$129K Hold
1,689
– – 0.02% 207
2023
Q3
$117K Hold
1,689
– – 0.02% 208
2023
Q2
$159K Hold
1,689
– – 0.03% 173
2023
Q1
$140K Sell
1,689
-38
-2% -$2.99K 0.03% 174
2022
Q4
$129K Buy
1,727
+1,447
+517% +$112K 0.03% 169
2022
Q3
$23K Buy
280
+56
+25% +$5.39K 0.01% 300
2022
Q2
$21K Sell
224
-9
-4% -$932 0.01% 242
2022
Q1
$27K Buy
233
+116
+99% +$13K 0.01% 244
2021
Q4
$15K Buy
+117
New +$13.6K ﹤0.01% 259

Other funds holding EW

American National Bank & Trust's EW Position: Q3 2026 in Review

American National Bank & Trust reduced its Edwards Lifesciences (EW) stake by 5.8% in Q3 2026, selling an estimated $7.91K and leaving 1,438 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #280.

American National Bank & Trust first reported a position in EW in Q4 2021 and has held it in 20 quarters since. The position peaked at $161K in Q1 2024. 153 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • American National Bank & Trust held 1,438 shares of Edwards Lifesciences worth $124K as of Q3 2026.
  • American National Bank & Trust sold 89 Edwards Lifesciences shares in Q3 2026, an estimated $7.91K.
  • Edwards Lifesciences made up 0.01% of American National Bank & Trust's portfolio in Q3 2026, its #280 holding.
  • American National Bank & Trust first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 20 quarters since.
  • American National Bank & Trust's Edwards Lifesciences position peaked at $161K in Q1 2024.
  • 153 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on American National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.